# Major Recall Alert: STA-Liatest D-Di Recalled Due to Risk of D-Dimer Level Underestimation
Stago has issued an official recall for its **STA-Liatest D-Di** product after customer complaints prompted an investigation. The company confirmed a potential risk of underestimating D-Dimer (D-Di) levels in two specific lots: **271382** and **271411**. Although no patient impacts have been reported, the recall was announced as a safety measure to maintain the highest standards of care.
Here’s what you need to know about this recall and how you can take action.
## Why This Recall Is Important
D-Dimer is a critical blood test parameter that aids in diagnosing blood clot-related conditions such as **deep vein thrombosis (DVT)** and **pulmonary embolism (PE)**. Accurate test results are essential for making timely and effective treatment decisions.
The affected lots of STA-Liatest D-Di demonstrated a potential underestimation of D-Dimer levels during clinical use. This issue may lead to healthcare providers making inaccurate diagnoses, delaying life-saving treatments. While there have been no reports of patient harm due to this issue, the recall is a proactive measure to ensure all patients receive accurate lab results.
This recall emphasizes the importance of stringent quality control in medical diagnostics and highlights how swift action can mitigate potential risks.
## Details of the Recall
Key information regarding the recall is outlined below:
- **Product Name**: STA-Liatest D-Di
- **Brand**: Stago
- **Lot Numbers**: 271382, 271411
- **Reason for Recall**: Potential risk of underestimation of D-Dimer (D-Di) levels due to detected inconsistencies in the two affected lots.
- **Date Announced**: [Insert Correct Date of Recall Announcement]
- **Reported Patient Impact**: None reported.
For more details and official updates, visit the official **Health Canada Recall Notice** here: [https://recalls-rappels.canada.ca/en/alert-recall/sta-liatest-di](https://recalls-rappels.canada.ca/en/alert-recall/sta-liatest-di).
## What You Should Do
If you use STA-Liatest D-Di in testing or diagnostics, here’s what you can do immediately:
- **Inspect Inventory**: Check your stock for the affected lots, 271382 and 271411.
- **Stop Using the Recalled Lots**: Discontinue using the identified batches immediately.
- **Contact the Manufacturer**: Reach out to Stago for replacements or further instructions.
- **Report Issues**: Share any concerns or patient safety incidents with Stago or appropriate regulatory authorities to ensure swift resolution.
For healthcare professionals, it’s essential to verify test results or consider retesting patients if the affected lots were previously used.
## Stay Safe – Get Instant Recall Alerts
In today’s fast-paced medical environment, staying informed about recalls is vital for patient safety and effective healthcare practices. To ensure you're always up to date, consider the following:
1. **Download Health Canada’s Official App**: Get instant alerts on product recalls and safety updates.
2. **Subscribe to Email Notifications**: Sign up for recall alerts from trusted health organizations.
3. **Bookmark Official Sources**: Keep tabs on updates by visiting Health Canada’s Recalls and Safety Alerts page regularly.
As recalls can have significant implications for healthcare standards, it’s critical to act promptly and stay informed.
---
**Final Reminder**: If you’re a healthcare provider or distributor handling STA-Liatest D-Di, take action to minimize risks. For comprehensive information, visit the official recall notice here: [https://recalls-rappels.canada.ca/en/alert-recall/sta-liatest-di](https://recalls-rappels.canada.ca/en/alert-recall/sta-liatest-di).
Stay informed and protect patient health. Download the Health Canada app today to never miss a recall alert!